17 Jul 2023 Tissue Regenix Group , the regenerative medical devices company, provides an unaudited trading update for the six months ended 30 June 2023 . .
10 Jul 2023 Tissue Regenix , the regenerative medical device company, announces that it has signed an exclusive distribution agreement with Joint Operations Ltd.
Business Update Continued progress on XF-73 partnering discussions Susan Koppy appointed to drive business development activities $2bn XF-73 Nasal market opportunity Brighton, United Kingdom - 29th June 2.